Our group will investigate new strategies to address very different pathologies that are presented in our emergency department, national referent in different fields of diagnosis and treatment. This heterogeneous group of specialists, will approach 6 main lines of research, which aim to contribute to the better definition of clinical, diagnostic and treatment strategies. We collaborate with other research groups, to study clinical and prognostic usefulness tests in cardiology, to develop new strategies for the treatment and diagnosis of infectious diseases, and to investigate new antibiotics with the pneumology group. We develop a new and pioneering line of imagingdiagnostic, with the line of emergency ultrasound, being national referents in research in this field, in which we have the active support of private enterprise. We will investigate the possibility of supporting us in new technologies that help the clinician in the decision making in the field of the treatment of the diabetes, impelling global initiatives both at the hospital and the population level. Finally, we will develop a line of toxicological research, focusing both on the early recognition of the intoxicated patient, as well as their adequate treatment, in collaboration with the clinical toxicology unit (CTU), with the aim of becoming a national reference center in the Management of the intoxicated patient, as well as in the development of protocols of attention to multiple victims of biological attack.